Pharma & Health

Pharma & Health – Modernizing Validated Systems With Precision

The DACH region is a global hub for pharmaceutical and life sciences – home to Roche, Novartis, Bayer, Boehringer Ingelheim, Merck KGaA, and Fresenius. The sector operates highly regulated, GxP-validated IT landscapes where every system change requires formal validation. Legacy LIMS, MES, clinical trial management, and pharmacovigilance platforms are increasingly expensive to maintain and validate – yet too critical and too regulated to modernize carelessly.

Modernizing pharma IT demands a combination of deep technical capability and regulatory fluency. GxP-validated migrations, SAP S/4HANA transformations, and AI deployment within GAMP 5 frameworks all require engineering teams that understand validation as a first-class deliverable, from project start.

GxP-Validated System Migration

Legacy LIMS, MES, and QMS platforms reach end-of-life or lose vendor support, yet every migration in a GxP environment requires full re-validation (IQ/OQ/PQ). Cloud-native target architectures add re-validation complexity – data residency, access control, and audit trail continuity all require documentation that satisfies both EU and FDA inspectors.

Successful migrations treat test generation and validation documentation as the critical path, on equal footing with the migration itself. Automated regression testing against validated baseline behavior shortens re-validation cycles while reducing human error. SAP ERP to S/4HANA migrations in pharmaceutical environments demand the same rigor – pharma-specific validation requirements on top of standard S/4HANA complexity.

A Software Quality Health Check assesses legacy LIMS/MES code quality and validation readiness before any migration commitment – typically completed in 1–2 weeks.

Healthcare Interoperability

Germany’s ePA rollout and the FHIR interoperability mandate are reshaping hospital IT. Krankenhausinformationssysteme (KIS) built on proprietary interfaces need modernization to exchange structured health data across provider networks. The Hospital Transformation Fund provides 50 billion euros in funding through 2035 – but only for organizations that meet defined interoperability standards.

FHIR-native healthcare data platforms replace point-to-point integrations with standardized, scalable architectures. A Host Integration Health Check evaluates the current integration landscape of clinical and manufacturing systems – identifying interoperability gaps and migration priorities in 1–2 weeks.

What We Deliver

We bring deep experience in regulated IT environments to pharma and healthcare organizations across the DACH region. Six concrete offerings address the sector’s most pressing modernization needs:

• GxP-validated cloud migration – We migrate legacy LIMS, MES, and QMS to cloud-native platforms with full re-validation documentation (IQ/OQ/PQ). Automated regression testing against validated baselines shortens re-validation cycles. SAP ERP to S/4HANA migrations include pharma-specific validation deliverables.

• Legacy system renovation and re-documentation – We reverse-engineer business logic from validated systems into structured formats, modernize aging laboratory and manufacturing platforms, and produce documentation that satisfies Annex 11 and ALCOA+ requirements. Performance tuning for SAP ERP and manufacturing workloads is included where applicable.

• Healthcare interoperability platforms – We modernize KIS for ePA/FHIR interoperability and design FHIR-native data platforms for standardized health data exchange across provider networks – aligned with Hospital Transformation Fund requirements.

• AI deployment under GxP governance – We deliver AI-based pharmacovigilance signal detection (NLP), predictive manufacturing quality, and clinical decision support – all within GDPR, EU AI Act, and GAMP 5 frameworks. Governance structures, explainability documentation, and audit trails are built in from the architecture level.

• Managed operations for validated systems – We provide ongoing application management for GxP-validated pharma and healthcare IT, including regulatory update implementation. Incident volumes decrease quarter over quarter because root causes are permanently eliminated.

• Managed Modernization under validation discipline – We combine daily operations with systematic renovation over 12–36 months. Validated systems are incrementally modernized while remaining in production and in compliance – with incremental re-validation.